ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Nexera Technologies shares plunge 19% to 52-week low

The stock hit $2.13 as investors reacted to the company’s acquisition of a 50.1% stake in Logia USA, funded partly by a $2 million credit line and share issuance.

PA
Priya Anand · Equities & Earnings Desk · 28 Aug 2026 · 14:57 · 1 min read
Share
Nexera Technologies shares plunge 19% to 52-week low

Shares of Nexera Technologies fell 19.3% in morning trading, touching a session low of $2.13—a level matching the company’s 52-week low.

The decline came as investors digested the company’s acquisition of a 50.1% stake in Logia USA Inc., a provider of fuel integrity solutions targeting the U.S. data center market. The transaction was structured through Nexera’s majority-owned subsidiary, Fort Technology Inc., which issued 132,603 new common shares valued at roughly $125,000 to complete the deal.

Fort also committed to a $2.0 million unsecured credit facility at 6% annual interest to support Logia USA’s expansion into the U.S. market. The financing underscores the capital-intensive nature of the transaction, which follows Nexera’s broader strategy of pursuing growth through strategic stakes in adjacent businesses.

Nexera Technologies, which carries deeply negative earnings and commands a market capitalization of approximately $1.5 million, has seen its share price decline amid concerns over dilution and execution risk tied to the acquisition. The broader market showed little movement on the day, with the NASDAQ Composite and S&P 500 essentially flat, indicating the slide was stock-specific rather than driven by broader macro factors.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT